{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T01:43:26Z","timestamp":1772329406682,"version":"3.50.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:00:00Z","timestamp":1603929600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:00:00Z","timestamp":1603929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11886-020-01429-4","type":"journal-article","created":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T13:02:33Z","timestamp":1603976553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Sarcoid Heart Disease: an Update on Diagnosis and Management"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4616-7928","authenticated-orcid":false,"given":"Sofia Carolina","family":"Masri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lavanya","family":"Bellumkonda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,29]]},"reference":[{"issue":"2","key":"1429_CR1","first-page":"149","volume":"18","author":"DS McGrath","year":"2001","unstructured":"McGrath DS, Goh N, Foley PJ, du Bois RM. Sarcoidosis: genes and microbes--soil or seed? Sarcoidosis Vasc Diffuse Lung Dis. 2001;18(2):149\u201364.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"4","key":"1429_CR2","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1055\/s-0030-1262208","volume":"31","author":"G Zissel","year":"2010","unstructured":"Zissel G, Prasse A, Muller-Quernheim J. Immunologic response of sarcoidosis. Semin Respir Crit Care Med. 2010;31(4):390\u2013403.","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"1429_CR3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","volume":"68","author":"DH Birnie","year":"2016","unstructured":"Birnie DH, Nery PB, Ha AC, Beanlands RS. Cardiac Sarcoidosis. J Am Coll Cardiol. 2016;68(4):411\u201321.","journal-title":"J Am Coll Cardiol"},{"issue":"7\u20138","key":"1429_CR4","first-page":"372","volume":"43","author":"K Iwai","year":"1993","unstructured":"Iwai K, Tachibana T, Takemura T, Matsui Y, Kitaichi M, Kawabata Y. Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan. Acta Pathol Jpn. 1993;43(7\u20138):372\u20136.","journal-title":"Acta Pathol Jpn"},{"issue":"3","key":"1429_CR5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","volume":"145","author":"BA Rybicki","year":"1997","unstructured":"Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145(3):234\u201341.","journal-title":"Am J Epidemiol"},{"issue":"7","key":"1429_CR6","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","volume":"131","author":"R Kandolin","year":"2015","unstructured":"\u2022\u2022 Kandolin R, Lehtonen J, Airaksinen J, Vihinen T, Miettinen H, Ylitalo K, et al. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015;131(7):624\u201332 This paper collect all cases of histologically confirmed cardiac sarcoidosis seen in Finland over 25 years. This work focus on epidemiology, characteristics and long-term outcomes of cardiac sarcoidosis.","journal-title":"Circulation"},{"issue":"1","key":"1429_CR7","first-page":"50","volume":"6","author":"E Hulten","year":"2016","unstructured":"Hulten E, Aslam S, Osborne M, Abbasi S, Bittencourt MS, Blankstein R. Cardiac sarcoidosis-state of the art review. Cardiovasc Diagn Ther. 2016;6(1):50\u201363.","journal-title":"Cardiovasc Diagn Ther"},{"issue":"8","key":"1429_CR8","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/jce.12401","volume":"25","author":"PB Nery","year":"2014","unstructured":"Nery PB, Beanlands RS, Nair GM, Green M, Yang J, McArdle BA, et al. Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults. J Cardiovasc Electrophysiol. 2014;25(8):875\u201381.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"3","key":"1429_CR9","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0002-8703(97)70070-X","volume":"134","author":"Y Yoshida","year":"1997","unstructured":"Yoshida Y, Morimoto S, Hiramitsu S, Tsuboi N, Hirayama H, Itoh T. Incidence of cardiac sarcoidosis in Japanese patients with high-degree atrioventricular block. Am Heart J. 1997;134(3):382\u20136.","journal-title":"Am Heart J"},{"issue":"12","key":"1429_CR10","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1161\/CIRCULATIONAHA.118.034687","volume":"138","author":"DR Okada","year":"2018","unstructured":"Okada DR, Smith J, Derakhshan A, Gowani Z, Misra S, Berger RD, et al. Ventricular arrhythmias in cardiac sarcoidosis. Circulation. 2018;138(12):1253\u201364.","journal-title":"Circulation."},{"issue":"5","key":"1429_CR11","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrcardio.2015.22","volume":"12","author":"N Hamzeh","year":"2015","unstructured":"Hamzeh N, Steckman DA, Sauer WH, Judson MA. Pathophysiology and clinical management of cardiac sarcoidosis. Nat Rev Cardiol. 2015;12(5):278\u201388.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"1429_CR12","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/0735-1097(91)90750-4","volume":"18","author":"SL Winters","year":"1991","unstructured":"Winters SL, Cohen M, Greenberg S, Stein B, Curwin J, Pe E, et al. Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol. 1991;18(4):937\u201343.","journal-title":"J Am Coll Cardiol"},{"issue":"37","key":"1429_CR13","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1093\/eurheartj\/ehz428","volume":"40","author":"K Ekstrom","year":"2019","unstructured":"Ekstrom K, Lehtonen J, Nordenswan HK, Mayranpaa MI, Raisanen-Sokolowski A, Kandolin R, et al. Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries. Eur Heart J. 2019;40(37):3121\u20138.","journal-title":"Eur Heart J"},{"issue":"4","key":"1429_CR14","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1378\/chest.11-3214","volume":"143","author":"JF Viles-Gonzalez","year":"2013","unstructured":"Viles-Gonzalez JF, Pastori L, Fischer A, Wisnivesky JP, Goldman MG, Mehta D. Supraventricular arrhythmias in patients with cardiac sarcoidosis prevalence, predictors, and clinical implications. Chest. 2013;143(4):1085\u201390.","journal-title":"Chest."},{"issue":"9","key":"1429_CR15","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.amjcard.2014.01.434","volume":"113","author":"MA Cain","year":"2014","unstructured":"Cain MA, Metzl MD, Patel AR, Addetia K, Spencer KT, Sweiss NJ, et al. Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias. Am J Cardiol. 2014;113(9):1556\u201360.","journal-title":"Am J Cardiol"},{"issue":"12","key":"1429_CR16","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jchf.2017.09.022","volume":"5","author":"P Raeisi-Giglou","year":"2017","unstructured":"Raeisi-Giglou P, Rodriguez ER, Blackstone EH, Tan CD, Hsich EM. Verification of heart disease: implications for a new heart transplantation allocation system. JACC Heart Fail. 2017;5(12):904\u201313.","journal-title":"JACC Heart Fail"},{"issue":"1","key":"1429_CR17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.amjcard.2008.08.053","volume":"103","author":"WC Roberts","year":"2009","unstructured":"Roberts WC, Vowels TJ, Ko JM, Capehart JE, Hall SA. Cardiac transplantation for cardiac sarcoidosis with initial diagnosis by examination of the left ventricular apical \u201ccore\u201d excised for insertion of a left ventricular assist device for severe chronic heart failure. Am J Cardiol. 2009;103(1):110\u20134.","journal-title":"Am J Cardiol"},{"issue":"6","key":"1429_CR18","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","volume":"58","author":"KJ Silverman","year":"1978","unstructured":"Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978;58(6):1204\u201311.","journal-title":"Circulation."},{"issue":"1","key":"1429_CR19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0002-9343(77)90121-8","volume":"63","author":"WC Roberts","year":"1977","unstructured":"Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med. 1977;63(1):86\u2013108.","journal-title":"Am J Med"},{"issue":"2","key":"1429_CR20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.hrthm.2012.10.019","volume":"10","author":"DG Dechering","year":"2013","unstructured":"Dechering DG, Kochhauser S, Wasmer K, Zellerhoff S, Pott C, Kobe J, et al. Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2013;10(2):158\u201364.","journal-title":"Heart Rhythm"},{"issue":"9","key":"1429_CR21","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.echo.2016.06.001","volume":"29","author":"E Joyce","year":"2016","unstructured":"Joyce E, Kamperidis V, Ninaber MK, Katsanos S, Debonnaire P, Schalij MJ, et al. Prevalence and correlates of early right ventricular dysfunction in sarcoidosis and its association with outcome. J Am Soc Echocardiogr. 2016;29(9):871\u20138.","journal-title":"J Am Soc Echocardiogr"},{"issue":"6","key":"1429_CR22","first-page":"e344","volume":"125","author":"EV Ward","year":"2012","unstructured":"Ward EV, Nazari J, Edelman RR. Coronary artery vasculitis as a presentation of cardiac sarcoidosis. Circulation. 2012;125(6):e344\u20136.","journal-title":"Circulation."},{"issue":"4","key":"1429_CR23","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.carpath.2006.02.005","volume":"15","author":"J Butany","year":"2006","unstructured":"Butany J, Bahl NE, Morales K, Thangaroopan M, Ross H, Rao V, et al. The intricacies of cardiac sarcoidosis: a case report involving the coronary arteries and a review of the literature. Cardiovasc Pathol. 2006;15(4):222\u20137.","journal-title":"Cardiovasc Pathol"},{"issue":"5","key":"1429_CR24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2796.2011.02396.x","volume":"270","author":"R Kandolin","year":"2011","unstructured":"Kandolin R, Lehtonen J, Graner M, Schildt J, Salmenkivi K, Kivisto SM, et al. Diagnosing isolated cardiac sarcoidosis. J Intern Med. 2011;270(5):461\u20138.","journal-title":"J Intern Med"},{"issue":"7","key":"1429_CR25","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","volume":"11","author":"DH Birnie","year":"2014","unstructured":"\u2022\u2022 Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11(7):1305\u201323 This document provides: 1) working criteria for the diagnosis of cardiac sarcoidosis based on expertise opinion and the limited available data; 2) guidance and recommendations for risk stratification for sudden cardiac death; 3) recommendations on appropriate indications implantable cardioverter-defibrillator implantation.","journal-title":"Heart Rhythm"},{"issue":"7","key":"1429_CR26","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/CIRCRESAHA.117.310982","volume":"121","author":"E Muchtar","year":"2017","unstructured":"Muchtar E, Blauwet LA, Gertz MA. Restrictive cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res. 2017;121(7):819\u201337.","journal-title":"Circ Res"},{"issue":"4","key":"1429_CR27","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s12350-016-0658-1","volume":"25","author":"DR Okada","year":"2018","unstructured":"Okada DR, Bravo PE, Vita T, Agarwal V, Osborne MT, Taqueti VR, et al. Isolated cardiac sarcoidosis: a focused review of an under-recognized entity. J Nucl Cardiol. 2018;25(4):1136\u201346.","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"1429_CR28","doi-asserted-by":"crossref","first-page":"e007030","DOI":"10.1161\/CIRCIMAGING.117.007030","volume":"11","author":"T Vita","year":"2018","unstructured":"Vita T, Okada DR, Veillet-Chowdhury M, Bravo PE, Mullins E, Hulten E, et al. Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis. Circ Cardiovasc Imaging. 2018;11(1):e007030.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"1429_CR29","doi-asserted-by":"crossref","first-page":"e007408","DOI":"10.1161\/CIRCIMAGING.117.007408","volume":"11","author":"EJ Miller","year":"2018","unstructured":"Miller EJ, Culver DA. Establishing an evidence-based method to diagnose cardiac sarcoidosis: the complementary use of cardiac magnetic resonance imaging and FDG-PET. Circ Cardiovasc Imaging. 2018;11(1):e007408.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"10","key":"1429_CR30","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/ehjci\/jex146","volume":"18","author":"Writing group; Document reading group; EACVI Reviewers: This document was reviewed by members of the EACVI Scientific Documents Committee for 2014\u20132016 and 2016\u20132018","year":"2017","unstructured":"\u2022\u2022 Writing group; Document reading group; EACVI Reviewers: This document was reviewed by members of the EACVI Scientific Documents Committee for 2014\u20132016 and 2016\u20132018. A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology. Eur Heart J Cardiovasc Imaging. 2017;18(10):1073\u201389 This joint position paper illustrate the role and correct use of imaging for evaluation and management of patients with known or suspected cardiac sarcoidosis. This position paper try to standardize imaging for cardiac sarcoidosis.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"21","key":"1429_CR31","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","volume":"357","author":"MC Iannuzzi","year":"2007","unstructured":"Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357(21):2153\u201365.","journal-title":"N Engl J Med"},{"issue":"11","key":"1429_CR32","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1540-8167.2011.02099.x","volume":"22","author":"JL Schuller","year":"2011","unstructured":"Schuller JL, Olson MD, Zipse MM, Schneider PM, Aleong RG, Wienberger HD, et al. Electrocardiographic characteristics in patients with pulmonary sarcoidosis indicating cardiac involvement. J Cardiovasc Electrophysiol. 2011;22(11):1243\u20138.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"4","key":"1429_CR33","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1542-474X.2009.00320.x","volume":"14","author":"M Homsi","year":"2009","unstructured":"Homsi M, Alsayed L, Safadi B, Mahenthiran J, Das MK. Fragmented QRS complexes on 12-lead ECG: a marker of cardiac sarcoidosis as detected by gadolinium cardiac magnetic resonance imaging. Ann Noninvasive Electrocardiol. 2009;14(4):319\u201326.","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"4","key":"1429_CR34","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1378\/chest.106.4.1021","volume":"106","author":"T Suzuki","year":"1994","unstructured":"Suzuki T, Kanda T, Kubota S, Imai S, Murata K. Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest. 1994;106(4):1021\u20134.","journal-title":"Chest."},{"issue":"7","key":"1429_CR35","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/0002-9149(89)90323-8","volume":"63","author":"DJ Burstow","year":"1989","unstructured":"Burstow DJ, Tajik AJ, Bailey KR, DeRemee RA, Taliercio CP. Two-dimensional echocardiographic findings in systemic sarcoidosis. Am J Cardiol. 1989;63(7):478\u201382.","journal-title":"Am J Cardiol"},{"issue":"1","key":"1429_CR36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ejhf.205","volume":"17","author":"E Joyce","year":"2015","unstructured":"Joyce E, Ninaber MK, Katsanos S, Debonnaire P, Kamperidis V, Bax JJ, et al. Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis. Eur J Heart Fail. 2015;17(1):51\u201362.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"1429_CR37","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.echo.2015.02.018","volume":"28","author":"M Orii","year":"2015","unstructured":"Orii M, Hirata K, Tanimoto T, Shiono Y, Shimamura K, Yamano T, et al. Myocardial damage detected by two-dimensional speckle-tracking echocardiography in patients with extracardiac sarcoidosis: comparison with magnetic resonance imaging. J Am Soc Echocardiogr. 2015;28(6):683\u201391.","journal-title":"J Am Soc Echocardiogr"},{"key":"1429_CR38","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.4076\/1752-1947-3-8573","volume":"3","author":"SR Patel","year":"2009","unstructured":"Patel SR. Systemic sarcoidosis with bone marrow involvement responding to therapy with adalimumab: a case report. J Med Case Rep. 2009;3:8573.","journal-title":"J Med Case Rep"},{"key":"1429_CR39","doi-asserted-by":"crossref","unstructured":"Smedema JP, Ainslie G, Crijns H. Review: contrast-enhanced magnetic resonance in the diagnosis and management of cardiac sarcoidosis. Prog Cardiovasc Dis. 2020.","DOI":"10.1016\/j.pcad.2020.03.011"},{"issue":"10","key":"1429_CR40","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jacc.2005.01.047","volume":"45","author":"JP Smedema","year":"2005","unstructured":"Smedema JP, Snoep G, van Kroonenburgh MP, van Geuns RJ, Dassen WR, Gorgels AP, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol. 2005;45(10):1683\u201390.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1429_CR41","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.jcmg.2019.12.011","volume":"13","author":"PS Velangi","year":"2020","unstructured":"Velangi PS, Chen KA, Kazmirczak F, Okasha O, von Wald L, Roukoz H, et al. Right ventricular abnormalities on cardiovascular magnetic resonance imaging in patients with sarcoidosis. JACC Cardiovasc Imaging. 2020;13(6):1395\u2013405.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"1429_CR42","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/jmri.24196","volume":"39","author":"Y Yang","year":"2014","unstructured":"Yang Y, Safka K, Graham JJ, Roifman I, Zia MI, Wright GA, et al. Correlation of late gadolinium enhancement MRI and quantitative T2 measurement in cardiac sarcoidosis. J Magn Reson Imaging. 2014;39(3):609\u201316.","journal-title":"J Magn Reson Imaging"},{"issue":"4","key":"1429_CR43","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","volume":"6","author":"S Greulich","year":"2013","unstructured":"Greulich S, Deluigi CC, Gloekler S, Wahl A, Zurn C, Kramer U, et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging. 2013;6(4):501\u201311.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"9","key":"1429_CR44","doi-asserted-by":"crossref","first-page":"e005001","DOI":"10.1161\/CIRCIMAGING.116.005001","volume":"9","author":"E Hulten","year":"2016","unstructured":"Hulten E, Agarwal V, Cahill M, Cole G, Vita T, Parrish S, et al. Presence of late gadolinium enhancement by cardiac magnetic resonance among patients with suspected cardiac sarcoidosis is associated with adverse cardiovascular prognosis: a systematic review and meta-analysis. Circ Cardiovasc Imaging. 2016;9(9):e005001.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"3","key":"1429_CR45","doi-asserted-by":"crossref","first-page":"e000867","DOI":"10.1161\/CIRCIMAGING.113.000867","volume":"9","author":"R Blankstein","year":"2016","unstructured":"Blankstein R, Waller AH. Evaluation of known or suspected cardiac sarcoidosis. Circ Cardiovasc Imaging. 2016;9(3):e000867.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"1429_CR46","doi-asserted-by":"crossref","first-page":"e003738","DOI":"10.1161\/CIRCIMAGING.115.003738","volume":"9","author":"G Murtagh","year":"2016","unstructured":"Murtagh G, Laffin LJ, Beshai JF, Maffessanti F, Bonham CA, Patel AV, et al. Prognosis of myocardial damage in sarcoidosis patients with preserved left ventricular ejection fraction: risk stratification using cardiovascular magnetic resonance. Circ Cardiovasc Imaging. 2016;9(1):e003738.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"2","key":"1429_CR47","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","volume":"53","author":"G Youssef","year":"2012","unstructured":"Youssef G, Leung E, Mylonas I, Nery P, Williams K, Wisenberg G, et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J Nucl Med. 2012;53(2):241\u20138.","journal-title":"J Nucl Med"},{"issue":"5","key":"1429_CR48","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s12350-017-0978-9","volume":"24","author":"P Chareonthaitawee","year":"2017","unstructured":"Chareonthaitawee P, Beanlands RS, Chen W, Dorbala S, Miller EJ, Murthy VL, et al. Joint SNMMI-ASNC expert consensus document on the role of (18)F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Cardiol. 2017;24(5):1741\u201358.","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"1429_CR49","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s12350-018-1379-4","volume":"27","author":"V Atterton-Evans","year":"2020","unstructured":"Atterton-Evans V, Turner J, Vivanti A, Robertson T. Variances of dietary preparation for suppression of physiological (18)F-FDG myocardial uptake in the presence of cardiac sarcoidosis: a systematic review. J Nucl Cardiol. 2020;27(2):481\u20139.","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"1429_CR50","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s12350-018-01488-9","volume":"26","author":"PE Bravo","year":"2019","unstructured":"Bravo PE, Singh A, Di Carli MF, Blankstein R. Advanced cardiovascular imaging for the evaluation of cardiac sarcoidosis. J Nucl Cardiol. 2019;26(1):188\u201399.","journal-title":"J Nucl Cardiol"},{"issue":"4","key":"1429_CR51","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","volume":"63","author":"R Blankstein","year":"2014","unstructured":"\u2022\u2022 Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol. 2014;63(4):329\u201336 This paper evaluates cardiac FDG PET to adverse cardiac events in patients with known or suspected cardiac sarcoidosis. This study showed that cardiac FDG PET offer prognostic value beyond Japanese Ministry of Health and Welfare clinical criteria.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1429_CR52","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","volume":"21","author":"MT Osborne","year":"2014","unstructured":"Osborne MT, Hulten EA, Singh A, Waller AH, Bittencourt MS, Stewart GC, et al. Reduction in (1)(8)F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol. 2014;21(1):166\u201374.","journal-title":"J Nucl Cardiol"},{"issue":"9","key":"1429_CR53","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.cjca.2013.02.004","volume":"29","author":"MM Sadek","year":"2013","unstructured":"Sadek MM, Yung D, Birnie DH, Beanlands RS, Nery PB. Corticosteroid therapy for cardiac sarcoidosis: a systematic review. Can J Cardiol. 2013;29(9):1034\u201341.","journal-title":"Can J Cardiol"},{"issue":"2","key":"1429_CR54","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1542-474X.2011.00418.x","volume":"16","author":"K Yodogawa","year":"2011","unstructured":"Yodogawa K, Seino Y, Ohara T, Takayama H, Katoh T, Mizuno K. Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis. Ann Noninvasive Electrocardiol. 2011;16(2):140\u20137.","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"3","key":"1429_CR55","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/CIRCEP.113.000734","volume":"7","author":"Y Naruse","year":"2014","unstructured":"Naruse Y, Sekiguchi Y, Nogami A, Okada H, Yamauchi Y, Machino T, et al. Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis. Circ Arrhythm Electrophysiol. 2014;7(3):407\u201313.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1429_CR56","doi-asserted-by":"crossref","unstructured":"Segawa M, Fukuda K, Nakano M, Kondo M, Satake H, Hirano M, et al. Time course and factors correlating with ventricular tachyarrhythmias after introduction of steroid therapy in cardiac sarcoidosis. Circ Arrhythm Electrophysiol. 2016;9(6).","DOI":"10.1161\/CIRCEP.115.003353"},{"key":"1429_CR57","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijcard.2016.10.101","volume":"227","author":"SK Padala","year":"2017","unstructured":"Padala SK, Peaslee S, Sidhu MS, Steckman DA, Judson MA. Impact of early initiation of corticosteroid therapy on cardiac function and rhythm in patients with cardiac sarcoidosis. Int J Cardiol. 2017;227:565\u201370.","journal-title":"Int J Cardiol"},{"issue":"9","key":"1429_CR58","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","volume":"88","author":"Y Yazaki","year":"2001","unstructured":"Yazaki Y, Isobe M, Hiroe M, Morimoto S, Hiramitsu S, Nakano T, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol. 2001;88(9):1006\u201310.","journal-title":"Am J Cardiol"},{"issue":"6","key":"1429_CR59","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.amjcard.2015.12.033","volume":"117","author":"T Nagai","year":"2016","unstructured":"\u2022 Nagai T, Nagano N, Sugano Y, Asaumi Y, Aiba T, Kanzaki H, et al. Effect of discontinuation of prednisolone therapy on risk of cardiac mortality associated with worsening left ventricular dysfunction in cardiac sarcoidosis. Am J Cardiol. 2016;117(6):966\u201371 This paper highlights the importance of maintenance steroid therapy and the risk of recurrent exacerbations of cardiac sarcoidosis.","journal-title":"Am J Cardiol"},{"issue":"23","key":"1429_CR60","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.2169\/internalmedicine.53.3120","volume":"53","author":"S Nagai","year":"2014","unstructured":"Nagai S, Yokomatsu T, Tanizawa K, Ikezoe K, Handa T, Ito Y, et al. Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions. Intern Med. 2014;53(23):2761.","journal-title":"Intern Med"},{"issue":"18","key":"1429_CR61","doi-asserted-by":"crossref","first-page":"e010952","DOI":"10.1161\/JAHA.118.010952","volume":"8","author":"DG Rosenthal","year":"2019","unstructured":"Rosenthal DG, Parwani P, Murray TO, Petek BJ, Benn BS, De Marco T, et al. Long-term corticosteroid-sparing immunosuppression for cardiac sarcoidosis. J Am Heart Assoc. 2019;8(18):e010952.","journal-title":"J Am Heart Assoc"},{"key":"1429_CR62","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ahj.2019.10.003","volume":"220","author":"D Birnie","year":"2020","unstructured":"\u2022\u2022 Birnie D, Beanlands RSB, Nery P, Aaron SD, Culver DA, DeKemp RA, et al. Cardiac sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT). Am Heart J. 2020;220:246\u201352 This is the first prospective randomized control trial comparing immunosuppression regimens in cardiac sarcoidosis.","journal-title":"Am Heart J"},{"issue":"1","key":"1429_CR63","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1378\/chest.94.1.202","volume":"94","author":"SL Demeter","year":"1988","unstructured":"Demeter SL. Myocardial sarcoidosis unresponsive to steroids. Treatment with cyclophosphamide. Chest. 1988;94(1):202\u20133.","journal-title":"Chest."},{"key":"1429_CR64","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijcard.2018.11.131","volume":"276","author":"T Ballul","year":"2019","unstructured":"Ballul T, Borie R, Crestani B, Daugas E, Descamps V, Dieude P, et al. Treatment of cardiac sarcoidosis: a comparative study of steroids and steroids plus immunosuppressive drugs. Int J Cardiol. 2019;276:208\u201311.","journal-title":"Int J Cardiol"},{"issue":"6","key":"1429_CR65","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.md.0000145367.17934.75","volume":"83","author":"C Chapelon-Abric","year":"2004","unstructured":"Chapelon-Abric C, de Zuttere D, Duhaut P, Veyssier P, Wechsler B, Huong DL, et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore). 2004;83(6):315\u201334.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"1429_CR66","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1183\/09031936.00195010","volume":"38","author":"DH Sahoo","year":"2011","unstructured":"Sahoo DH, Bandyopadhyay D, Xu M, Pearson K, Parambil JG, Lazar CA, et al. Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis. Eur Respir J. 2011;38(5):1145\u201350.","journal-title":"Eur Respir J"},{"issue":"10","key":"1429_CR67","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.amjcard.2019.07.067","volume":"124","author":"LJ Harper","year":"2019","unstructured":"\u2022\u2022 Harper LJ, McCarthy M, Ribeiro Neto ML, Hachamovitch R, Pearson K, Bonanno B, et al. Infliximab for refractory cardiac sarcoidosis. Am J Cardiol. 2019;124(10):1630\u20135 This study evaluate the role of TNF alfa inhibitors in refractory cardiac sarcoidosis.","journal-title":"Am J Cardiol"},{"issue":"6","key":"1429_CR68","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"CW Yancy","year":"2017","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, et al. 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017;136(6):e137\u2013e61.","journal-title":"Circulation."},{"issue":"13","key":"1429_CR69","first-page":"e272","volume":"138","author":"SM Al-Khatib","year":"2018","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018;138(13):e272\u2013391.","journal-title":"Circulation."},{"issue":"9","key":"1429_CR70","doi-asserted-by":"crossref","first-page":"e007488","DOI":"10.1161\/CIRCEP.119.007488","volume":"12","author":"F Kazmirczak","year":"2019","unstructured":"\u2022 Kazmirczak F, Chen KA, Adabag S, von Wald L, Roukoz H, Benditt DG, et al. Assessment of the 2017 AHA\/ACC\/HRS guideline recommendations for implantable cardioverter-defibrillator implantation in cardiac sarcoidosis. Circ Arrhythm Electrophysiol. 2019;12(9):e007488 This study validates the recommendations for ICD therapy in patients with CS.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"1429_CR71","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCEP.110.958322","volume":"4","author":"D Mehta","year":"2011","unstructured":"Mehta D, Mori N, Goldbarg SH, Lubitz S, Wisnivesky JP, Teirstein A. Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation. Circ Arrhythm Electrophysiol. 2011;4(1):43\u20138.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1429_CR72","doi-asserted-by":"crossref","unstructured":"Pandya K, Vaidya A, Cheng R, Baran D, Despasquale E (2020) Management of cardiac sarcoidosis post heart transplantation: survey of transplant centers. J Heart Lung Transplant. 39(4)","DOI":"10.1016\/j.healun.2020.01.567"},{"issue":"6","key":"1429_CR73","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cardfail.2018.02.009","volume":"24","author":"TC Crawford","year":"2018","unstructured":"\u2022 Crawford TC, Okada DR, Magruder JT, Fraser C, Patel N, Houston BA, et al. A contemporary analysis of heart transplantation and bridge-to-transplant mechanical circulatory support outcomes in cardiac sarcoidosis. J Card Fail. 2018;24(6):384\u201391 This study evaluates role of advanced therapies for patients with CS in the contemporary era.","journal-title":"J Card Fail"},{"issue":"7","key":"1429_CR74","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.healun.2007.05.006","volume":"26","author":"AR Zaidi","year":"2007","unstructured":"Zaidi AR, Zaidi A, Vaitkus PT. Outcome of heart transplantation in patients with sarcoid cardiomyopathy. J Heart Lung Transplant. 2007;26(7):714\u20137.","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"1429_CR75","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12350-013-9677-3","volume":"20","author":"M Osborne","year":"2013","unstructured":"Osborne M, Kolli S, Padera RF, Naya M, Lewis E, Dorbala S, et al. Use of multimodality imaging to diagnose cardiac sarcoidosis as well as identify recurrence following heart transplantation. J Nucl Cardiol. 2013;20(2):310\u20132.","journal-title":"J Nucl Cardiol"},{"issue":"11","key":"1429_CR76","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.healun.2005.02.016","volume":"24","author":"JE Yager","year":"2005","unstructured":"Yager JE, Hernandez AF, Steenbergen C, Persing B, Russell SD, Milano C, et al. Recurrence of cardiac sarcoidosis in a heart transplant recipient. J Heart Lung Transplant. 2005;24(11):1988\u201390.","journal-title":"J Heart Lung Transplant"},{"issue":"8","key":"1429_CR77","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.cjca.2018.03.021","volume":"34","author":"DG Rosenthal","year":"2018","unstructured":"Rosenthal DG, Anderson ME, Petek BJ, Arnett DM, Bravo PE, Raghu G, et al. Invasive hemodynamics and rejection rates in patients with cardiac sarcoidosis after heart transplantation. Can J Cardiol. 2018;34(8):978\u201382.","journal-title":"Can J Cardiol"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-020-01429-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-020-01429-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-020-01429-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T12:50:44Z","timestamp":1605012644000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-020-01429-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,29]]},"references-count":77,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1429"],"URL":"https:\/\/doi.org\/10.1007\/s11886-020-01429-4","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,29]]},"assertion":[{"value":"25 September 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"177"}}